Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Tonix Pharmaceuticals Holding (TNXP) Asset Utilization Ratio (2023 - 2025)

Tonix Pharmaceuticals Holding (TNXP) has 3 years of Asset Utilization Ratio data on record, last reported at 0.05 in Q3 2025.

  • For Q3 2025, Asset Utilization Ratio fell 48.47% year-over-year to 0.05; the TTM value through Sep 2025 reached 0.05, down 48.47%, while the annual FY2024 figure was 0.06, N/A changed from the prior year.
  • Asset Utilization Ratio reached 0.05 in Q3 2025 per TNXP's latest filing, down from 0.05 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.09 in Q3 2024 and bottomed at 0.05 in Q3 2025.
  • Average Asset Utilization Ratio over 3 years is 0.07, with a median of 0.06 recorded in 2024.
  • Peak YoY movement for Asset Utilization Ratio: skyrocketed 52.63% in 2024, then crashed 48.47% in 2025.
  • A 3-year view of Asset Utilization Ratio shows it stood at 0.05 in 2023, then surged by 52.63% to 0.08 in 2024, then plummeted by 40.17% to 0.05 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.05 in Q3 2025, 0.05 in Q2 2025, and 0.06 in Q1 2025.